Oncolytics Biotech's total assets for Q4 2024 were C$20.19M, a decrease of -16.80% from the previous quarter. TSE:ONC total liabilities were C$14.20M for the fiscal quarter, a -6.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.